Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
C21orf119
REST API REST API
Homo sapiens
C21orf119 is differentially expressed in 110 experiments: 43 organism parts: prostate, cerebellum, ... (41 more);, 36 disease states: normal, pancreatic carcinoma, ... (34 more);, 41 cell types 219 cell lines 10 compound treatments and 37 other conditions.
Synonyms MGC14136, PRED84
UniProt Accession Q96HZ7
Search EB-eye ENSG00000256073
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-8167, E-MTAB-37, E-GEOD-6573, E-MTAB-69, E-GEOD-6919, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-MEXP-2197, ... (19 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-20081, E-GEOD-19639, E-GEOD-5823
HepG2
1
2
E-GEOD-21154, E-MTAB-37, E-GEOD-7307
J82
1
E-MTAB-37
SNU449
1
E-MTAB-37
HCC38
1
E-MTAB-37
NCIH630
1
E-MTAB-37
213 more value(s).


Cell type

studied in E-GEOD-15893, E-GEOD-20193, E-GEOD-20033, E-TABM-130, E-GEOD-1460, ... (20 experiments)

Factor Value U/D Experiments
LCC
1
E-GEOD-19188
neutrophil
1
E-GEOD-12662
CD34 positive
1
E-GEOD-12662
iPSC derived from hASC using lentiviral reprogramming vector
1
E-GEOD-20033
astrocyte
1
E-GEOD-4483
liver cancer
1
E-GEOD-21154
35 more value(s).


Disease state

studied in E-GEOD-19743, E-GEOD-6872, E-GEOD-15960, E-MEXP-1121, E-MEXP-2069, ... (17 experiments)

Factor Value U/D Experiments
breast carcinoma
1
E-MTAB-37
bronchogenic carcinoma
1
E-MTAB-37
gulf war illness
1
E-MEXP-2069
epilepsy
1
E-GEOD-4290
adenoma
1
E-GEOD-15960
B-cell neoplasm
1
E-MTAB-37
30 more value(s).


Compound treatment

studied in E-GEOD-3284, E-TABM-127, E-MEXP-2241, E-GEOD-7307, E-GEOD-20081 ... (5 experiments)

Factor Value U/D Experiments
bacterial endotoxin
1
E-GEOD-3284
control
9
1
E-GEOD-3284
unknown
1
E-GEOD-7307
ethanol
1
E-MEXP-2241
Cxcl12
1
E-GEOD-7307
estradiol
1
E-GEOD-20081
4 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-MTAB-37, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-20847, E-MTAB-108, E-MEXP-563

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-MEXP-421, E-TABM-601, E-MEXP-1838, ... (6 experiments)

Growth condition
studied in E-GEOD-7011, E-MEXP-2657, E-TABM-127, E-MEXP-1103, E-MEXP-2146 ... (5 experiments)

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-19330, E-GEOD-19519, E-GEOD-6919, ... (16 experiments)

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-17636

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19246

RNAi
studied in E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Treatment
studied in E-GEOD-12198

Processing time: 0.601 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM